No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study)

BACKGROUND: Understanding the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination will enable accurate counseling and inform evolving vaccination strategies. Little is known about antibody response following booster vaccination in people living with HIV (PLWH)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kling, Kendall D., Janulis, Patrick, Demonbreun, Alexis R., Sancilio, Amelia, Berzins, Baiba, Krueger, Karen, Achenbach, Chad, Price, Rachelle, Sullivan, Margaret, Caputo, Matthew, Hockney, Sara, Zembower, Teresa, McDade, Thomas W., Taiwo, Babafemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868861/
https://www.ncbi.nlm.nih.gov/pubmed/36700200
http://dx.doi.org/10.3389/fimmu.2022.1048776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868861/
https://www.ncbi.nlm.nih.gov/pubmed/36700200
http://dx.doi.org/10.3389/fimmu.2022.1048776

Ejemplares similares